METTL3 antagonizes 5FU chemotherapy and confers drug resistance in colorectal carcinoma. Li M, Xia M, Zhang Z, Tan Y, et al. Int J Oncol 2022;61.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li M, Xia M, Zhang Z, Tan Y, et al. METTL3 antagonizes 5FU chemotherapy and confers drug resistance in colorectal carcinoma. Int J Oncol 2022;61.
PMID: 35856434